Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. [electronic resource]
- BMC infectious diseases Nov 2013
- 537 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2334
10.1186/1471-2334-13-537 doi
Adult Anti-HIV Agents--therapeutic use Drug Resistance, Viral Female Genotype HIV Infections--drug therapy HIV-1--classification Humans Male Phylogeny Superinfection--drug therapy Treatment Failure